1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop drugs? Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999‚ and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research‚ and (2) developing partnerships with smaller biotechnology companies. Since 1995‚ Merck had launched
Premium Expected value License Money
including Bayer AG and Novartis are exploring a deal for Merck & Co Inc’s consumer healthcare business‚ as they seek to gain scale in a fragmented industry‚ according to several people familiar with the matter. Reckitt Benckiser Group PLC and Procter & Gamble Co are also among the parties that have held discussions with Merck about buying the unit‚ best known for Coppertone sunscreen and Claritin allergy medicine‚ the sources said this week. The Merck business‚ which also includes Dr. Scholl’s foot
Premium Pharmacology Marketing Pharmacy
consolidation with the fittest carriers surviving and the rest being acquired or going out of business. Analysis of the airline industry To determine the profitability of the airline industry‚ we will do an industry analysis using Porter’s five-forces framework. This industry analysis will help us in understanding the size of the Potential Industry Earnings (PIE)‚ and how much of this the different participants can extract. Rivalry among competitors There is intense rivalry among different
Premium Southwest Airlines Airline Aircraft
TO: Dr. Roy Vagelos‚ Chairman and CEO Merck Corporation. January‚ 1991. The decision to move forward with the program to donate the new drug Mectizan on a large scale to the affected population in the Third World needs to be systematically analyzed. There are two especially important angles from which this decision needs to be considered. The first concern that needs to be taken into account is that of the stockholders and investors in this company‚ whose interests you are ultimately charged with
Premium Medicine Pharmacology Pharmacy
Marketing and distribution The Company distributes its products principally through third-party computer resellers. The Company is also continuing its expansion into new distribution channels‚ such as mass merchandise stores‚ consumer electronics outlets and computer superstores‚ in response to changing industry practices and customer preferences. The Company’s products are sold primarily to business and government customers through independent resellers‚ value-added resellers and systems integrators;
Premium United States
Pharmaceuticals: Merck Sustaining Long-term Advantage Through Information Technology Hiroshi Amari Working Paper No. 161 Working Paper Series Center on Japanese Economy and Business Columbia Business School December 1998 Columbia-Yale Project: Use of Software to Achieve Competitive Advantage PHARMACEUTICALS: MERCK Sustaining Long-term Advantage Through Information Technology Prepared by Hiroshi Amari Research Associate‚ Yale University William V. Rapp and Hugh T. Patrick Co-principal
Premium Clinical trial Pharmaceutical industry Drug development
IKEA‚ the Swedish furniture conglomerate‚ has taken on aggressive growth goals over the past several years in an effort to remain competitive. With this in mind‚ Michael Porter ’s "5 Forces" are applied to IKEA for better understanding of the organization as such: INTERNAL RIVALRY/COMPETITORS- The organization operates in a highly competitive industry‚ characterized by other low priced furniture producers such as Galiform of England and retailers such as Wal-Mart of the United States. Internally
Free IKEA Power Force
product differentiation in this industry is low‚ the switching costs are also low. Therefore‚ the competitive force coming from customer bargaining power is very strong. Supplier Bargaining Power: There is a scarce amount of raw materials for steel in this industry and there are very few suppliers for them. Most of the materials are imported into the United States. Therefore‚ the competitive force coming from supplier bargaining power is moderate to weak. Potential New Entrants: Again‚ there is low access
Premium Marketing English-language films Competition
Industry Analysis Using: Michael Porter’s Industry Forces Model Reebok International‚ Ltd. (1995): The Nike Challenge Case Authored By: Thomas L. Wheelen‚ Moustafa H. Abdelsamad‚ Shirley E. Fieber‚ and Judith D. Smith Analysis By: Tim Sacks Threat of New Entrants Barriers to Entry The athletic shoe industry is slowly becoming a global oligopoly. There are many barriers to entry preventing new entrants from capturing significant market share. Large athletic
Premium Barriers to entry Athletic shoe Shoe
Porter’s 5 Forces Low Threat of Entry Ryanair benefiting from large economies of scale and have massively reduced long run average costs. They have struck deals with Boeing and Airbus for reduced prices (1/3rd of listed price) on 737 aircraft in bulk buying therefore new entrants to the market will not get these reduced prices as they do not hold a similar relationship and they will not be able to order in bulk. Ryanair have struck deals with many local airports over flight paths and
Premium Airline Low-cost carrier Southwest Airlines